Thư viện Trường Đại học Phú Xuân
VTCSOM Block V Preparation Materials

Nguồn ngoài

VTCSOM Block V Preparation Materials

Tác giả
Renée LeClair
Nhà xuất bản
Virginia Tech Carilion School of Medicine
Nguồn
LibreTexts
Giấy phép
CC BY-NC-SA
Ngôn ngữ
EN
Mục lục· 429 mục
  1. 01: Basic Microbiology and Infection Control
  2. 1.01: Classification - The Three Domain System
  3. 1.02: Sizes Shapes and Arrangements of Bacteria
  4. 1.03: The Peptidoglycan Cell Wall
  5. 1.3.01: Damage of the Cell Wall
  6. 1.3A: The Gram-Positive Cell Wall
  7. 1.3B: The Gram-Negative Cell Wall
  8. 1.3C: The Acid-Fast Cell Wall
  9. 1.04: Structures Outside the Cell Wall
  10. 1.4A: Glycocalyx (Capsules) and Biofilms
  11. 1.4B: Flagella
  12. 1.4C: Fimbriae and Pili
  13. 1.05: Cellular Components within the Cytoplasm
  14. 1.5A: Cytoplasm
  15. 1.5B: The Bacterial Chromosome and Nucleoid
  16. 1.5C: Plasmids and Transposons
  17. 1.5D: Ribosomes
  18. 1.5E: Endospores
  19. 1.5F: Inclusion Bodies and Organelles Used for Photosynthesis
  20. 1.06: An Overview to Control of Microorganisms
  21. 1.07: Ways in which Chemical Control Agents Affect Bacteria
  22. 1.08: Ways in which Bacteria May Resist Chemical Control Agents
  23. 02: Pathogenicity
  24. 2.01: Overview of Microbe-Host Interactions
  25. 2.1A: Normal Microbiota and Host Relationships
  26. 2.1B: Opportunistic Microorganisms
  27. 2.1C: Cooperation Among Microorganisms
  28. 2.02: Penetrating Host Defenses
  29. 2.2A: Penetrating Host Defenses
  30. 2.2B: Pili and Pilus Assembly
  31. 2.2C: Biofilms and Infections
  32. 2.03: Damaging Host Cells
  33. 2.3A: Toxins
  34. 2.3B: Direct Damage
  35. 2.3C: Type III and Type IV Secretion
  36. 2.3D: Plasmids and Lysogeny
  37. 2.3E: Siderophores
  38. 2.04: Surviving Within the Host and Exiting the Host
  39. 2.4A: Intracellular Pathogens
  40. 2.4B: Extracellular Immune Avoidance
  41. 2.4C: Regulating Virulence
  42. 2.4D: Portals of Exit
  43. 2.05: Pathogenicity and Other Microbes
  44. 2.5A: Fungi
  45. 2.5B: Protozoa
  46. 2.5C: Helminths
  47. 2.5D: Algae
  48. 03: Bacteria
  49. 3.01: Clostridium tetani
  50. 3.02: Escherichia coli
  51. 3.03: Haemophilus influenzae
  52. 3.04: Helicobacter pylori
  53. 3.05: Neisseria gonorrhoeae
  54. 3.06: Neisseria meningitidis
  55. 3.07: Staphylococcus aureus
  56. 3.08: Streptococcus pneumoniae
  57. 3.09: Streptococcus pyogenes
  58. 3.10: Vibrio cholerae
  59. 04: Culturing Bacteria
  60. 4.01: Culture Media
  61. 4.02: Complex and Synthetic Media
  62. 4.03: Selective and Differential Media
  63. 4.04: Aseptic Technique Dilution Streaking and Spread Plates
  64. 4.05: Special Culture Techniques
  65. 05: Entry into the Host
  66. 5.01: Portals of Microbe Entry
  67. 5.02: Colonization and Growth
  68. 5.03: Pathogenicity Islands and Virulence Factors
  69. 5.04: Adherence
  70. 5.05: Host Risk Factors
  71. 5.06: Innate Resistance
  72. 06: Bacterial Infections
  73. 6.01: Bacterial Diseases of the Respiratory System
  74. 6.1A: Pharyngitis
  75. 1.01: Scarlet Fever
  76. 6.1C: Diphtheria
  77. 6.1D: Otitis Media
  78. 6.1E: Whooping Cough
  79. 6.1F: Tuberculosis
  80. 6.1G: Bacterial Pneumonias
  81. 6.02: Bacterial Diseases of the Mouth
  82. 6.2A: Tooth and Gum Infections
  83. 6.2B: Dental Caries
  84. 6.2C: Periodontal Disease
  85. 6.03: Bacterial Diseases of the Digestive System
  86. 6.3A: Bacterial Gastroenteritis
  87. 6.3B: Staphylococcal Food Poisoning
  88. 6.3C: Salmonellosis
  89. 6.3D: Typhoid Fever
  90. 6.3E: Cholera
  91. 6.3F: Noncholera Vibrios
  92. 6.3G: Pathogenic Escherichia coli
  93. 6.3H: Campylobacter
  94. 6.3I: Peptic Ulcer Disease
  95. 6.3J: Listeriosis
  96. 6.04: Bacterial Diseases of the Urinary System
  97. 6.4A: Urinary Tract Infection (UTI)
  98. 6.4B: Cystitis
  99. 6.4C: Pyelonephritis
  100. 6.4D: Leptospirosis
  101. 6.05: Bacterial Diseases of the Reproductive System
  102. 6.5A: Prostatitis
  103. 6.5B: Prostatitis
  104. 6.5C: Gonorrhea
  105. 6.5D: Nongonococcal Urethritis (NGU)
  106. 6.5E: Pelvic Inflammatory Disease (PID)
  107. 6.5F: Syphilis
  108. 6.5G: Genital Ulcer Diseases
  109. 6.5H: Lymphogranuloma Venereum
  110. 6.5I: Group B Streptococcus Colonization
  111. 6.5J: Chancroid (Soft Chancre)
  112. 6.5K: Bacterial Vaginosis
  113. 6.5L: Chlamydia
  114. 6.06: Microbial Diseases of the Skin
  115. 6.6A: Structure of the Skin- Epidermis
  116. 6.6B: Microbiota of the Skin
  117. 6.6C: Bacterial Skin Diseases
  118. 6.6D: Viral Skin Diseases
  119. 6.6E: Fungal Skin and Nail Diseases
  120. 6.6F: Parasitic Skin Diseases
  121. 6.07: Microbial Diseases of the Eye
  122. 6.7A: Anatomy of the Eye
  123. 6.7B: Normal Eye Microbiota
  124. 6.7C: Bacterial Eye Diseases
  125. 6.7D: Other Infectious Eye Diseases
  126. 6.08: Microbial Diseases of the Nervous System
  127. 6.8A: Functions of the Nervous System
  128. 6.8B: Subdivisions of the Nervous System
  129. 6.8C: Meningitis
  130. 6.8D: Botulism
  131. 6.8E: Leprosy
  132. 6.8F: Tetanus
  133. 6.8G: Paralysis-Causing Bacterial Neurotoxins
  134. 07: Innate Nonspecific Host Defenses
  135. 7.01: Physical Defenses
  136. 7.02: Chemical Defenses
  137. 7.03: Cellular Defenses
  138. 7.04: Pathogen Recognition and Phagocytosis
  139. 08: Basic Immunology Review
  140. 8.01: Overview of the Immune System
  141. 8.02: Anatomical Barriers to Infection Mechanical Removal of Microbes and Bacterial Antagonism by Normal Body Microbiota
  142. 8.03: Cells and Organs of the Immune System
  143. 8.04: Antimicrobial Enzymes and Antimicrobial Peptides
  144. 8.05: The Complement System
  145. 09: Innate Immunity
  146. 9.01: Overview of Immunity
  147. 9.02: The Innate Immune Response
  148. 9.03: The Innate Immune System- An Overview
  149. 9.04: Overview of Human-Microbial Reactions
  150. 9.05: Natural Killer Cells
  151. 9.06: Physical and Chemical Barriers
  152. 9.07: The Complement System
  153. 9.08: Pathogen Recognition
  154. 9.09: Defense Cells in the Blood- The Leukocytes
  155. 9.10: Defense Cells in the Tissue - Dendritic Cells Macrophages and Mast Cells
  156. 9.11: Early Induced Innate Immunity
  157. 9.11A: Pathogen-Associated Molecular Patterns (PAMPs) and Danger-Associated Molecular Patterns (DAMPs)
  158. 9.11B: Pattern-Recognition Receptors (PRRs)
  159. 9.11C: Cytokines Important in Innate Immunity
  160. 9.11D: Harmful Effects Associated with Abnormal Pattern-Recognition Receptor Responses Variations in Innate Immune Signaling Pathways and or Levels of Cytokine Production
  161. 9.11E: Phagocytosis
  162. 9.11F: Natural Killer Cells (NK Cells) and Invariant Natural Killer T-Lymphocytes (iNKT Cells)
  163. 9.11G: Inflammation
  164. 9.11H: Nutritional Immunity
  165. 9.11I: Fever
  166. 9.11J: The Acute Phase Response
  167. 9.11K: Intraepithelial T-lymphocytes and B-1 cells
  168. 10: Adaptive Immunity
  169. 10.01: Immunodeficiency
  170. 10.1.E: Immunodeficiency (Exercises)
  171. 10.02: Hypersensitivities
  172. 10.2.E: Hypersensitivities (Exercises)
  173. 10.03: Introduction to Adaptive Immunity
  174. 10.3.01: An Overview of Innate and Adaptive Immunity
  175. 10.3.02: Antigens and Epitopes
  176. 10.3.03: Major Cells and Key Cell Surface Molecules Involved in Adaptive Immune Responses
  177. 10.3.3A: Major Histocompatibility Complex (MHC) Molecules
  178. 10.3.3B: Antigen-Presenting Cells (APCs)
  179. 10.3.3C: T4-Lymphocytes (T4-Cells)
  180. 10.3.3D: T8-Lymphocytes (T8-Cells)
  181. 10.3.3E: Invarient Natural Killer T-Lymphocytes (iNKT Cells)
  182. 10.3.3F: B-Lymphocytes (B-Cells)
  183. 10.3.3G: Natural Killer Cells (NK Cells)
  184. 10.3.04: The Lymphoid System
  185. 10.3.05: An Overview of the Steps Involved in Adaptive Immune Responses
  186. 10.3.E: Introduction to Adaptive Immunity (Exercises)
  187. 10.04: Humoral Immunity
  188. 10.4.01: Antibodies (Immunoglobulins)
  189. 10.4.1B: Antibody Structure
  190. 10.4.1C: The 5 Classes (Isotypes) of Human Antibodies
  191. 10.4.1D: Generation of Antibody Diversity
  192. 10.4.1E: Clonal Selection and Clonal Expansion
  193. 10.4.1F: Anamnestic (Memory) Response
  194. 10.4.02: Ways That Antibodies Help to Defend the Body
  195. 10.4.2A: Opsonization
  196. 10.4.2B: Cytolysis by the Membrane Attack Complex (MAC)
  197. 10.4.2C: Antibody-dependent Cellular Cytotoxicity (ADCC) by Natural Killer Cells
  198. 10.4.2D: Neutralization of Exotoxins
  199. 10.4.2E: Neutralization of Viruses
  200. 10.4.2F: Preventing Bacterial Adherence
  201. 10.4.2G: Agglutination of Microorganisms
  202. 10.4.2H: Immobilization of Bacteria and Protozoans
  203. 10.4.2I: Promoting an Inflammatory Response
  204. 10.4.03: Naturally and Artificially Acquired Active and Passive Immunity
  205. 10.4.3A: Naturally Acquired Immunity
  206. 10.4.3B: Artificially Acquired Immunity
  207. 10.4.E: Humoral Immunity (Exercises)
  208. 10.05: Cell-Mediated Immunity
  209. 10.5.01: Cell-Mediated Immunity - An Overview
  210. 10.5.02: Activating Antigen-Specific Cytotoxic T- Lymphocytes
  211. 10.5.03: Activating Macrophages and NK Cells
  212. 10.5.04: Stimulating Cells to Secrete Cytokines
  213. 10.5.E: Cell-Mediated Immunity (Exercises)
  214. 11: Specific Adaptive Host Defenses
  215. 11.01: Architecture of the Immune System
  216. 11.02: Antigens Antigen Presenting Cells and Major Histocompatibility Complexes
  217. 11.03: T Lymphocytes
  218. 11.04: B Lymphocytes and Antibodies
  219. 12: Hypersensitivities
  220. 12.01: Type I (Anaphylactic) Reactions
  221. 12.02: Diagnosis and Treatment of Allergy
  222. 12.03: Type II (Cytotoxic) Reactions
  223. 12.04: Type III (Immune Complex) Reactions
  224. 12.05: Type IV (Delayed Cell-Mediated) Reactions
  225. 12.06: Immunity Disorders- Hypersensitivity
  226. 13: Laboratory Analysis of the Immune Response
  227. 13.01: Practical Applications of Monoclonal and Polyclonal Antibodies
  228. 13.02: Detecting Antigen-Antibody Complexes in vitro
  229. 13.03: Agglutination Assays
  230. 13.04: Enzyme Immunoassays (EIA) and Enzyme-Linked Immunosorbent Assays (ELISA)
  231. 13.05: Fluorescent Auto-Antibody Techniques
  232. 13.E: Laboratory Analysis of the Immune Response (Exercises)
  233. 14: Immunodeficiencies
  234. 14.01: Immunity Disorders- Autoimmune Diseases
  235. 14.1A: Immunodeficiency
  236. 14.02: Autoimmune Disorders
  237. 14.03: Superantigens
  238. 14.04: Immunity Disorders- Immunodeficiencies
  239. 14.05: Cell-Mediated Autoimmune Reactions
  240. 14.06: Immune Complex Autoimmune Reactions
  241. 14.07: Cytotoxic Autoimmune Reactions
  242. 14.08: Primary Immunodeficiency
  243. 14.09: Primary Immunodeficiency Diseases
  244. 14.10: Secondary Immunodeficiency
  245. 14.11: Secondary Immunodeficiency Diseases
  246. 14.12: Immunotherapy for Cancer
  247. 14.13: The Roles of Genetics and Gender in Autoimmune Disease
  248. 15: Acellular Pathogens
  249. 15.01: Viruses
  250. 15.02: The Viral Life Cycle
  251. 15.03: Isolation Culture and Identification of Viruses
  252. 15.04: Viroids Virusoids and Prions
  253. 15.05: Viral Replication
  254. 15.5A: General Features of Virus Replication
  255. 15.5B: Steps of Virus Infections
  256. 15.5C: Tissue Tropism in Animal Viruses
  257. 15.5D: Animal Viruses
  258. 15.5E: Plant Virus Life Cycles
  259. 15.06: Viral Diversity
  260. 15.6A: Overview of Bacterial Viruses
  261. 15.6B: RNA Bacteriophages
  262. 15.6C: Single-Stranded DNA Bacteriophages
  263. 15.6D: Double-Stranded DNA Bacteriophages
  264. 15.6E: Mu- A Double-Stranded Transposable DNA Bacteriophage
  265. 15.6F: Virulent Bacteriophages and T4
  266. 15.6G: Temperate Bacteriophages - Lambda and P1
  267. 15.6H: Viruses of Archaea
  268. 15.07: Positive-Strand RNA Viruses in Animals
  269. 15.7A: Positive-Strand RNA Viruses of Animals
  270. 15.7B: Virus Attachment and Genome Entry
  271. 15.7C: Viral Replication and Gene Expression
  272. 15.7D: Viral Exit
  273. 15.08: Retroviruses- Double-Stranded RNA Viruses
  274. 15.8A: Double-Stranded RNA Viruses - Retroviruses
  275. 15.8B: HIV Attachment and Host Cell Entry
  276. 15.8C: Retroviral RNA Genome
  277. 15.8D: Replicative Cycle of HIV
  278. 15.09: Negative-Strand RNA Viruses in Animals
  279. 15.9.01: Negative-Strand RNA Viruses of Animals
  280. 15.9.02: Attachment and Entry to the Host Cell
  281. 15.9.03: Replicative Cycle of Influenza A
  282. 15.10: DNA Viruses in Eukaryotes
  283. 15.10.01: Plant DNA Viruses
  284. 15.10.02: Replication of Double-Stranded DNA Viruses of Animals
  285. 15.10.03: Double-Stranded DNA Viruses - Herpesviruses
  286. 15.10.04: Attachment and Entry of Herpes Simplex
  287. 15.10.05: Replication of Herpes Simplex Virus
  288. 15.10.06: Immunodeficiency
  289. 15.10.07: Double-Stranded DNA Viruses - Pox Viruses
  290. 15.10.08: Double-Stranded DNA Viruses- Adenoviruses
  291. 15.10.09: Retroviruses and Hepadnavirus
  292. 15.10.10: Treatment of Animal Viral Infections
  293. 15.11: Viruses and Cancer
  294. 15.11.01: Cancer Viruses
  295. 15.11.02: DNA Oncogenic Viruses
  296. 15.11.03: RNA Oncogenic Viruses
  297. 15.12: Overview of Viruses
  298. 15.12.01: Discovery and Detection of Viruses
  299. 15.12.02: Nature of the Virion
  300. 15.12.03: Viral Genomes
  301. 15.12.04: Host Range
  302. 15.12.05: Viral Size
  303. 15.13: Structure of Viruses
  304. 15.13A: Viral Morphology
  305. 15.13B: General Morphology
  306. 15.13C: Complex and Asymmetrical Virus Particles
  307. 15.14: Classifying Viruses
  308. 15.14.01: The International Committee on Taxonomy of Viruses
  309. 15.14.02: The Baltimore Virus Classification
  310. 15.14.03: Evolution of Viruses
  311. 15.14.04: Medical Importance of Viruses
  312. 15.15: Culturing Viruses
  313. 15.15A: Batch Culture of Bacteriophages
  314. 15.15B: Tissue Culture of Animal Viruses
  315. 15.15C: Inoculation of Live Animals
  316. 15.15D: Viral Identification
  317. 15.16: Subviral Entities
  318. 15.16A: Defective Viruses
  319. 15.16B: Viroids
  320. 15.16C: Prions
  321. 15.17: Viral Ecology
  322. 15.17A: Emergence of Viral Pathogens
  323. 15.17B: Viral Roles in Ecosystems
  324. 16: The Eukaryotes of Microbiology
  325. 16.01: Unicellular Eukaryotic Microorganisms
  326. 16.02: Parasitic Helminths
  327. 16.03: Fungi
  328. 16.04: Algae
  329. 16.05: Lichens
  330. 16.E: The Eukaryotes of Microbiology (Exercises)
  331. 17: Systemic Infections
  332. 17.01: Respiratory System Infections
  333. 17.1.01: Anatomy and Normal Microbiota of the Respiratory Tract
  334. 17.1.02: Bacterial Infections of the Respiratory Tract
  335. 17.1.03: Viral Infections of the Respiratory Tract
  336. 17.1.04: Respiratory Mycoses
  337. 17.1.E: Respiratory System Infections (Exercises)
  338. 17.02: Urogenital System Infections
  339. 17.2.01: Anatomy and Normal Microbiota of the Urogenital Tract
  340. 17.2.02: Bacterial Infections of the Urinary System
  341. 17.2.03: Bacterial Infections of the Reproductive System
  342. 17.2.04: Viral Infections of the Reproductive System
  343. 17.2.05: Fungal Infections of the Reproductive System
  344. 17.2.06: Protozoan Infections of the Reproductive System
  345. 17.2.E: Urogenital System Infections (Exercises)
  346. 17.03: Digestive System Infections
  347. 17.3.01: Anatomy and Normal Microbiota of the Digestive System
  348. 17.3.02: Microbial Diseases of the Mouth and Oral Cavity
  349. 17.3.03: Bacterial Infections of the Gastrointestinal Tract
  350. 17.3.04: Viral Infections of the Gastrointestinal Tract
  351. 17.3.05: Protozoan Infections of the Gastrointestinal Tract
  352. 17.3.06: Helminthic Infections of the Gastrointestinal Tract
  353. 17.3.E: Digestive System Infections (Exercises)
  354. 17.04: Circulatory and Lymphatic System Infections
  355. 17.4.01: Anatomy of the Circulatory and Lymphatic Systems
  356. 17.4.02: Bacterial Infections of the Circulatory and Lymphatic Systems
  357. 17.4.03: Viral Infections of the Circulatory and Lymphatic Systems
  358. 17.4.04: Parasitic Infections of the Circulatory and Lymphatic Systems
  359. 17.4.E: Circulatory and Lymphatic System Infections (Exercises)
  360. 17.05: Nervous System Infections
  361. 17.5.01: Anatomy of the Nervous System
  362. 17.5.02: Bacterial Diseases of the Nervous System
  363. 17.5.03: Acellular Pathogenic Diseases of the Nervous System
  364. 17.5.04: Neuromycoses and Parasitic Diseases of the Nervous System
  365. 17.5.E: Nervous System Infections (Exercises)
  366. 17.06: Fungal Diseases of the Respiratory System
  367. 17.6.01: Histoplasmosis
  368. 17.6.02: Coccidiomycosis
  369. 17.6.03: Pneumocystis Pneumonia
  370. 17.6.04: Blastomycosis
  371. 17.6.05: Other Fungi Involved in Respiratory Disease
  372. 17.07: Fungal and Protozoan Diseases of the Digestive System
  373. 17.7.01: Ergot Poisoning
  374. 17.7.02: Aflatoxin Poisoning
  375. 17.7.03: Giardiasis
  376. 17.7.04: Cryptosporidiosis
  377. 17.7.05: Cyclospora Diarrheal Infection
  378. 17.7.06: Amoebic Dysentery (Amoebiasis)
  379. 17.7.07: Legionellosis
  380. 17.08: Helminthic Diseases of the Digestive System
  381. 17.8.01: Tapeworms
  382. 17.8.02: Hydatid Disease
  383. 17.8.03: Nematodes
  384. 17.09: Fungal and Protozoan Diseases of the Reproductive System
  385. 17.9.01: Vulvovaginal Candidiasis
  386. 17.9.02: Trichomoniasis
  387. 17.9.03: The TORCH Panel of Tests
  388. 17.10: Fungal Skin and Nail Diseases
  389. 17.11: Parasitic Skin Diseases
  390. 17.12: Other Infectious Eye Diseases
  391. 17.13: Fungal Protozoan Prion and Other Diseases of the Nervous System
  392. 17.13.01: Cryptococcosis
  393. 17.13.02: African Trypanosomiasis
  394. 17.13.03: Amoebic Meningoencephalitis
  395. 17.13.04: Bovine Spongiform Encephalopathy
  396. 17.13.05: Variant Creutzfeldt-Jakob Disease
  397. 17.13.06: Chronic Fatigue Syndrome
  398. 18: Immunization
  399. 18.01: Passive Immunization
  400. 18.02: Vaccination
  401. 18.03: Types of Vaccines
  402. 18.04: Development of New Vaccines
  403. 18.05: Vaccine Safety
  404. 19: Vaccine Safety
  405. 19.01: Non-Severe Events
  406. 19.02: Anaphylaxis
  407. 19.03: Vaccine Facts
  408. 19.04: Self Assessment
  409. 19.05: Vaccine Safety
  410. 19.06: Evaluation of Vaccines Pre-License
  411. 19.07: Canada Vigilance Program
  412. 19.08: Reflective Questions
  413. 19.09: Key Takeaways
  414. 19.10: References
  415. 20: Human Health and Disease
  416. 20.01: Human Health and Disease
  417. 20.02: The Gut Microbiome
  418. 20.03: The Oral Microbiome
  419. 20.04: The Skin Microbiome
  420. 20.05: The Respiratory Microbiome
  421. 20.06: The Vaginal Microbiome
  422. 20.07: Mental Health and Multi-Microbiome Interactions
  423. 21: Cancer Immunobiology and Immunotherapy
  424. 22: Skin and Eye Infections
  425. 22.01: Anatomy and Normal Microbiota of the Skin and Eyes
  426. 22.02: Bacterial Infections of the Skin and Eyes
  427. 22.03: Viral Infections of the Skin and Eyes
  428. 22.04: Mycoses of the Skin and Eyes
  429. 22.05: Protozoan and Helminthic Infections of the Eyes